{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:49:42Z","timestamp":1788997782141,"version":"build-2803163510"},"reference-count":28,"publisher":"Consortium of Multiple Sclerosis Centers","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:title>CME\/CNE Information<\/jats:title><jats:sec><jats:title\/><jats:p>Activity Available Online:<\/jats:p><jats:p>To access the article, post-test, and evaluation online, go to http:\/\/www.cmscscholar.org.<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Target Audience:<\/jats:p><jats:p>The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS).<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Learning Objectives:<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Accreditation Statement:<\/jats:p><jats:p>In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.<\/jats:p><jats:sec><jats:title\/><jats:p>Physician Credit<\/jats:p><jats:p>The CMSC designates this journal-based activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)\u2122. Physicians should claim only the credit commensurate with the extent of their participation in the activity.<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Nurse Credit<\/jats:p><jats:p>The CMSC designates this enduring material for 1.0 contact hours (none in the area of pharmacology).<\/jats:p><\/jats:sec><\/jats:sec><jats:sec><jats:title\/><jats:p>Disclosures:<\/jats:p><jats:p>Editor in Chief of the International Journal of MS Care (IJMSC), has served as Physician Planner for this activity. He has received royalties from Springer Publishing, intellectual property rights\/patent holder from Biogen, and consulting fees from Ipsen Pharma and has performed contracted research for Biogen, Adamas Pharmaceuticals, and Acorda Therapeutics.Francois Bethoux, MD,<\/jats:p><jats:p>has served as reviewer for this activity. She has disclosed no relevant financial relationships.Laurie Scudder, DNP, NP,<\/jats:p><jats:p>received salary from Pacific Rehabilitation Centers in Puyallup, WA, for conducting psychological evaluations (once weekly, July 2016\u2013August 2017).Salene M.W. Jones, PhD,<\/jats:p><jats:p>, has disclosed no relevant financial relationships.Rana Salem, MA<\/jats:p><jats:p>, has disclosed no relevant financial relationships.Dagmar Amtmann, PhD<\/jats:p><jats:p>The peer reviewers for the IJMSC have disclosed no relevant financial relationships.<\/jats:p><jats:p>The staff at the IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.<\/jats:p><jats:p>Note: Disclosures listed for authors are those applicable at the time of their work on this project and within the previous 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Method of Participation:<\/jats:p><jats:p>Release Date: June 1, 2018<\/jats:p><jats:p>Valid for Credit Through: June 1, 2019<\/jats:p><jats:p>In order to receive CME\/CNE credit, participants must:<\/jats:p><jats:p>Statements of Credit are awarded upon successful completion of the post-test with a passing score of &amp;gt;70% and the evaluation.<\/jats:p><jats:p>There is no fee to participate in this activity.<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Disclosure of Unlabeled Use:<\/jats:p><jats:p>This educational activity may contain discussion of published and\/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group.<\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p>Disclaimer:<\/jats:p><jats:p>Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.<\/jats:p><\/jats:sec>","DOI":"10.7224\/1537-2073.2017-069","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T17:22:32Z","timestamp":1528305752000},"page":"145-152","source":"Crossref","is-referenced-by-count":14,"title":["Somatic Symptoms of Depression and Anxiety in People with Multiple Sclerosis"],"prefix":"10.7224","volume":"20","author":[{"given":"Salene M.W.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Amtmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4242","reference":[{"key":"2020060301082957000_i1537-2073-20-3-145-b1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S0317167100047351","article-title":"Epidemiology of multiple sclerosis: a critical overview","volume":"20","author":"Sadovnick","year":"1993","journal-title":"Can J Neurol Sci"},{"key":"2020060301082957000_i1537-2073-20-3-145-b2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cpr.2008.12.001","article-title":"A review of psychological correlates of adjustment in patients with multiple sclerosis","volume":"29","author":"Dennison","year":"2009","journal-title":"Clin Psychol Rev"},{"key":"2020060301082957000_i1537-2073-20-3-145-b3","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1176\/appi.ajp.159.11.1862","article-title":"Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample","volume":"159","author":"Chwastiak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"2020060301082957000_i1537-2073-20-3-145-b4","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"2020060301082957000_i1537-2073-20-3-145-b5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/ajp.156.3.480","article-title":"Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms","volume":"156","author":"Silverstein","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2020060301082957000_i1537-2073-20-3-145-b6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/0021-843X.117.2.300","article-title":"The cultural shaping of depression: somatic symptoms in China, psychological symptoms in North America?","volume":"117","author":"Ryder","year":"2008","journal-title":"J Abnorm Psychol"},{"key":"2020060301082957000_i1537-2073-20-3-145-b7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4088\/PCC.v07n0405","article-title":"The importance of somatic symptoms in depression in primary care","volume":"7","author":"Tylee","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"2020060301082957000_i1537-2073-20-3-145-b8","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11136-015-0927-5","article-title":"Assessing measurement invariance of three depression scales between neurologic samples and community samples","volume":"24","author":"Chung","year":"2015","journal-title":"Qual Life Res"},{"key":"2020060301082957000_i1537-2073-20-3-145-b9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2014.09.002","article-title":"A differential item function analysis of somatic symptoms of depression in people with cancer","volume":"170","author":"Jones","year":"2015","journal-title":"J Affect Disord"},{"key":"2020060301082957000_i1537-2073-20-3-145-b10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/da.20658","article-title":"Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V","volume":"27","author":"Andrews","year":"2010","journal-title":"Depress Anxiety"},{"key":"2020060301082957000_i1537-2073-20-3-145-b11","volume-title":"Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic","author":"Barlow","year":"2004","edition":"2nd ed"},{"key":"2020060301082957000_i1537-2073-20-3-145-b12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2020060301082957000_i1537-2073-20-3-145-b13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3399\/bjgp08X263794","article-title":"Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care","volume":"58","author":"Cameron","year":"2008","journal-title":"Br J Gen Pract"},{"key":"2020060301082957000_i1537-2073-20-3-145-b14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.addbeh.2007.09.017","article-title":"Comparing the BDI-II and the PHQ-9 with outpatient substance abusers","volume":"33","author":"Dum","year":"2008","journal-title":"Addict Behav"},{"key":"2020060301082957000_i1537-2073-20-3-145-b15","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.3399\/bjgp09X454070","article-title":"Comparison of two self-rating scales to detect depression: HADS and PHQ-9","volume":"59","author":"Hansson","year":"2009","journal-title":"Br J Gen Pract"},{"key":"2020060301082957000_i1537-2073-20-3-145-b16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10790268.2009.11760766","article-title":"Patient Health Questionnaire-9 in spinal cord injury: an examination of factor structure as related to gender","volume":"32","author":"Kalpakjian","year":"2009","journal-title":"J Spinal Cord Med"},{"key":"2020060301082957000_i1537-2073-20-3-145-b17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1037\/a0035919","article-title":"Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis","volume":"59","author":"Amtmann","year":"2014","journal-title":"Rehabil Psychol"},{"key":"2020060301082957000_i1537-2073-20-3-145-b18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"2020060301082957000_i1537-2073-20-3-145-b19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/135245850100700311","article-title":"Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test","volume":"7","author":"Bowen","year":"2001","journal-title":"Mult Scler"},{"key":"2020060301082957000_i1537-2073-20-3-145-b20","first-page":"395","article-title":"Some latent trait models and their use in inferring an examinee's ability","author":"Birnbaum","year":"1968","journal-title":"Statistical Theories of Mental Test Scores"},{"key":"2020060301082957000_i1537-2073-20-3-145-b21","first-page":"19","article-title":"A study of item bias, using item characteristic curve theory","author":"Lord","year":"1977","journal-title":"Basic Problems in Cross-Cultural Psychology"},{"key":"2020060301082957000_i1537-2073-20-3-145-b22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"key":"2020060301082957000_i1537-2073-20-3-145-b23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/13803390802484789","article-title":"Clinical correlates of generalized worry in multiple sclerosis","volume":"31","author":"Bruce","year":"2009","journal-title":"J Clin Exp Neuropsychol"},{"key":"2020060301082957000_i1537-2073-20-3-145-b24","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.apmr.2004.07.348","article-title":"Symptoms of major depression in people with spinal cord injury: implications for screening","volume":"85","author":"Bombardier","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"2020060301082957000_i1537-2073-20-3-145-b25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","article-title":"The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review","volume":"32","author":"Kroenke","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"key":"2020060301082957000_i1537-2073-20-3-145-b26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"2020060301082957000_i1537-2073-20-3-145-b27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7224\/1537-2073.2014-008","article-title":"The 7-item Generalized Anxiety Disorder scale as a tool for measuring generalized anxiety in multiple sclerosis","volume":"17","author":"Terrill","year":"2015","journal-title":"Int J MS Care"},{"key":"2020060301082957000_i1537-2073-20-3-145-b28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1191\/1352458503ms930oa","article-title":"Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis","volume":"9","author":"Janssens","year":"2003","journal-title":"Mult Scler"}],"container-title":["International Journal of MS Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/20\/3\/145\/2092885\/1537-2073_2017-069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/20\/3\/145\/2092885\/1537-2073_2017-069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:12:31Z","timestamp":1752786751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijmsc.org\/view\/somatic-symptoms-of-depression-and-anxiety-in-people-with-multiple-sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.7224\/1537-2073.2017-069","relation":{},"ISSN":["1537-2073"],"issn-type":[{"value":"1537-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,1]]}}}